Somatropin
Somatropin (HGH, Genotropin, Norditropin): FDA-approved uses, the federal law on off-label distribution, label warnings and WADA status.
FDA-approved, prescription only · Evidence grade A · Reviewed
- FDA-approvedGrowth failureChildren with growth hormone deficiency and other labeled conditions
- FDA-approvedAdult growth hormone deficiencyDiagnosed deficiency only
- Not approvedAnti-aging and muscleNot approved; distribution for these uses is a federal crime
WADA prohibits growth hormone at all times under S2 (peptide hormones, growth factors, related substances and mimetics).
Drug-tested athletes can look up any substance on Global DRO, run by national anti-doping agencies. Supplements can contain banned substances that are not on the label. Drawline does not suggest when to train or inject.
Somatropin (Human growth hormone, HGH, GH, Genotropin, Norditropin, Humatrope, Omnitrope, Saizen, Zomacton, Serostim). Growth hormone (biologic).
AFDA-approved, prescription only. Evidence grade A: approved, large human trials.
What is Somatropin?
Somatropin is lab-made human growth hormone, a protein made by the pituitary gland that drives growth in children and affects metabolism in adults. It is sold under many brand names as an injection.
Is Somatropin FDA-approved?
FDA has approved somatropin products for growth failure from growth hormone deficiency, Turner syndrome, Prader-Willi syndrome, Noonan syndrome, SHOX deficiency, small for gestational age, idiopathic short stature and adult growth hormone deficiency; Serostim is approved for HIV-associated wasting. Each brand carries its own set of approved uses. HGH is not a scheduled controlled substance, but federal law (21 U.S.C. 333(e)) makes it a crime, punishable by up to 5 years in prison, to knowingly distribute it or possess it with intent to distribute for any human use other than a disease or condition FDA has authorized, on a physician's order. Somatropin products moved from drug approvals to biologics licenses on March 23, 2020.
What does the evidence show for Somatropin?
Strong evidence from decades of controlled trials and long-term registries in children and adults with growth hormone deficiency and the other approved conditions. Evidence for use outside these conditions, such as anti-aging or athletic performance, is weak and does not support benefit.
What are the known risks of Somatropin?
Labels warn of a higher risk of a second tumor in childhood cancer survivors, raised blood sugar, raised pressure in the skull, pancreatitis and slipped hip growth plates in children. Sudden deaths have been reported in children with Prader-Willi syndrome who are severely obese or have breathing problems. It must not be used with active cancer or certain diabetic eye disease. WADA prohibits growth hormone at all times under S2 (peptide hormones, growth factors, related substances and mimetics).
How is Somatropin measured?
Pens and cartridges are pre-measured. Powder vials are labeled in mg or IU: enter the amount in the vial and the water added, and the calculator shows the syringe units for a prescribed dose. Products sold online as "research use only" have no assurance of identity, dose or sterility. The calculator can do the arithmetic for any vial, but it cannot tell you what is actually in one.
Sources: U.S. Code: 21 U.S.C. 333, Penalties (subsection e, human growth hormone); DEA Diversion Control: Human Growth Hormone fact sheet; FDA label: Genotropin (somatropin), 2025; DailyMed: Genotropin (somatropin) label; FDA: Deemed to be a License provision of the BPCI Act. This profile does not recommend any dose or use.
For research and educational use. Not medical advice. Regulatory status changes, so confirm the current position with FDA or a licensed professional.
Keep reading
Spot a mistake or an out-of-date fact? Report an error. We check every report against the sources.